Ubs Group Ag Optimize Rx Corp Transaction History

Ubs Group Ag

$528 Billion
Q1 2025

A detailed history of Ubs Group Ag transactions in Optimize Rx Corp stock. As of the latest transaction made, Ubs Group Ag holds 12,135 shares of OPRX stock, worth $147,318. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,135

Previous 26,370 53.98%

Holding current value

$147,318

Previous $128,000 17.97%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$4.14 - $9.47 $58,932 - $134,805	-14,235 Reduced 53.98%	12,135 $105,000
Q4 2024 Feb 14, 2025	BUY	$3.83 - $7.83 $69,330 - $141,738	18,102 Added 218.94%	26,370 $128,000
Q3 2024 Nov 14, 2024	BUY	$7.2 - $11.23 $21,117 - $32,937	2,933 Added 54.98%	8,268 $63,000
Q2 2024 Aug 13, 2024	SELL	$8.8 - $13.17 $93,288 - $139,615	-10,601 Reduced 66.52%	5,335 $53,000
Q1 2024 May 13, 2024	BUY	$11.47 - $16.17 $12,731 - $17,948	1,110 Added 7.49%	15,936 $193,000
Q4 2023 Feb 09, 2024	BUY	$7.06 - $14.49 $43,927 - $90,156	6,222 Added 72.32%	14,826 $212,000
Q3 2023 Nov 09, 2023	SELL	$7.43 - $14.96 $7,355 - $14,810	-990 Reduced 10.32%	8,604 $66,000
Q2 2023 Aug 11, 2023	BUY	$11.63 - $15.63 $53,823 - $72,335	4,628 Added 93.19%	9,594 $137,000
Q1 2023 May 12, 2023	SELL	$12.54 - $19.38 $3,837 - $5,930	-306 Reduced 5.8%	4,966 $72,000
Q4 2022 Feb 08, 2023	BUY	$13.77 - $22.04 $45,096 - $72,181	3,275 Added 164.0%	5,272 $88,000
Q3 2022 Nov 10, 2022	BUY	$13.74 - $30.13 $20,403 - $44,743	1,485 Added 290.04%	1,997 $29,000
Q2 2022 Aug 10, 2022	SELL	$21.94 - $40.49 $410,102 - $756,839	-18,692 Reduced 97.33%	512 $14,000
Q1 2022 May 16, 2022	BUY	$35.27 - $62.91 $461,014 - $822,296	13,071 Added 213.13%	19,204 $724,000
Q4 2021 Feb 14, 2022	BUY	$53.57 - $98.0 $118,282 - $216,384	2,208 Added 56.25%	6,133 $381,000
Q3 2021 Nov 15, 2021	SELL	$50.93 - $85.55 $5,856 - $9,838	-115 Reduced 2.85%	3,925 $336,000
Q2 2021 Aug 13, 2021	BUY	$42.76 - $63.33 $114,853 - $170,104	2,686 Added 198.38%	4,040 $250,000
Q1 2021 May 12, 2021	SELL	$33.36 - $62.2 $74,192 - $138,332	-2,224 Reduced 62.16%	1,354 $66,000
Q4 2020 Feb 11, 2021	BUY	$19.04 - $33.1 $66,582 - $115,750	3,497 Added 4317.28%	3,578 $111,000
Q3 2020 Nov 12, 2020	SELL	$12.99 - $21.78 $75,160 - $126,019	-5,786 Reduced 98.62%	81 $2,000
Q2 2020 Jul 31, 2020	SELL	$8.34 - $13.69 $22,251 - $36,524	-2,668 Reduced 31.26%	5,867 $76,000
Q1 2020 May 01, 2020	SELL	$6.71 - $11.4 $56,800 - $96,501	-8,465 Reduced 49.79%	8,535 $77,000
Q4 2019 Feb 14, 2020	BUY	$8.8 - $14.08 $38,693 - $61,909	4,397 Added 34.89%	17,000 $175,000
Q3 2019 Nov 14, 2019	BUY	$13.6 - $16.96 $141,997 - $177,079	10,441 Added 482.93%	12,603 $182,000
Q2 2019 Aug 14, 2019	BUY	$10.43 - $16.62 $22,549 - $35,932	2,162 New	2,162 $35,000

Others Institutions Holding OPRX

# of Institutions

Shares Held

12.7M

Call Options Held

70.5K

Put Options Held

146K

View Full List

About OptimizeRx Corp

Ticker OPRX
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 18,023,100
Market Cap $219M
Description
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patien...

More about OPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account